51. CREB is a potential marker associated with drug-induced liver injury: Identification and validation through transcriptome database analysis
- Author
-
Qiyue, Zhang, Shiori, Taniguchi, Kanako, So, Masahiro, Tsuda, Yuriko, Higuchi, Mitsuru, Hashida, and Fumiyoshi, Yamashita
- Subjects
NF-E2-Related Factor 2 ,Gene Expression Profiling ,Humans ,Chemical and Drug Induced Liver Injury ,Cyclic AMP Response Element-Binding Protein ,Transcriptome ,Toxicology ,Biomarkers - Abstract
Drug-induced liver injury (DILI) is the main cause of failure in drug development and postapproval withdrawal. Although toxicogenomic techniques provide an unprecedented opportunity for mechanistic assessment and biomarker discovery, they are not suitable for the screening of large numbers of exploratory compounds in early drug discovery. Using a comprehensive analysis of toxicogenomics (TGx) data, we aimed to find DILI-relevant transcription factors (TFs) that could be incorporated into a reporter gene assay system. Gene set enrichment analysis (GSEA) of the Open TG-GATEs dataset highlighted 4 DILI-relevant TFs, including CREB, NRF2, ELK-1, and E2F. Using ten drugs with already assigned idiosyncratic toxicity (IDT) risks, reporter gene assays were conducted in HepG2 cells in the presence of the S9 mix. There were weak correlations between NRF2 activity and IDT risk, whereas strong correlations were observed between CREB activity and IDT risk. In addition, CREB activation associated with 3 Withdrawn/Black box Warning drugs was reversed by pretreatment with a PKA inhibitor. Collectively, we suggest that CREB might be a sensitive biomarker for DILI prediction, and its response to stress induced by high-risk drugs might be primarily regulated by the PKA/CREB signaling pathway.
- Published
- 2022